secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quoin Pharmaceuticals, Ltd. (QNRX)
CIK:        0001671502
Form:       8-K
Filed at:   2024-04-09T23:59:59+00:00
Accession:  0001104659-24-045210
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Quoin shareholders approve issuance of shares to Alumni Capital LP
------------------------------------------------------------------

- Special meeting on April 5, 2024 approved Alumni Issuance Proposal.
- Vote: 56,626 for, 23,469 against, 2,338 abstain; no broker non-votes.
- Approval allows issuance of up to maximum ordinary shares (ADSs) per Jan 25, 2024 purchase agreement.
- Alumni Capital LP is the counterparty; potential dilution from new share issuance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671502/000110465924045210/0001104659-24-045210-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671502/000110465924045210/tm2411437d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-045210

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer